Literature DB >> 24122275

Reliability of fractional anisotropy measurement for children with cerebral palsy.

Kyunghoon Min1, Su Jin Yu1, Ji Hyun Lee1, Junyoung Song1, Jae Sun Shim1, Hee Song Lee1, Sang Heum Kim2, MinYoung Kim1.   

Abstract

OBJECTIVE: Periventricular leukomalacia (PVL) is the leading cause of disability in children with cerebral palsy (CP). Diffusion tensor imaging (DTI) is a magnetic resonance imaging technique for detecting microstructural lesions of white matter. Fractional anisotropy (FA) is a widely used DTI index with clinical significance in children with CP. This study aims to estimate the reliability of FA for children with CP.
DESIGN: Four observers measured FA values in 78 children with spastic CP from PVL. Region of interests (ROIs) were placed in three anatomical loci at each side: medial and lateral portions of posterior limb of internal capsule and ascending sensory tract. Intra- and interobserver reliability indices including intraclass correlation coefficient (ICC), standard error of measurement, smallest real difference percentage (SRD%), and limit of agreement using Bland-Altman analysis were examined.
RESULTS: Intraobserver ICCs were 0.85 or greater in all ROIs, and SRD% ranged from 3.59 to 12.33%. Interobserver ICCs exceeded 0.90 in all ROIs, and the SRD% were less than 10%. The Bland-Altman analysis showed good intra- and interobserver agreements. The reliability was not affected by severity of impairment.
CONCLUSIONS: Reliability of DTI-derived FA value using ROIs was satisfactory in children with PVL. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24122275     DOI: 10.1055/s-0033-1357480

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  1 in total

1.  Assessment of pressure pain thresholds in collisions with collaborative robots.

Authors:  Moon Young Park; Doyeon Han; Jung Ho Lim; Min Kyung Shin; Young Rok Han; Dong Hwan Kim; Sungsoo Rhim; Kyung Sook Kim
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.